News & Trends - Pharmaceuticals

New PBS listings to bring hope for Australians living with kidney disease, cystic fibrosis and cancer

Health Industry Hub | February 3, 2020 |
[Total: 1    Average: 5/5]

There’s new hope for Australians living with chronic kidney disease, cystic fibrosis, and tumours of the midgut, thanks to new and amended medicines listings on the Pharmaceutical Benefits Scheme (PBS) from 1 February 2020.

The Morrison Government listed Pharmacor Cinacalcet on the PBS to help more patients with chronic kidney disease who are on dialysis.

In 2017, about 17,000 Australians lost their lives to chronic kidney disease. This disease accounts for about 1.8 million hospitalisations – or 16% of all hospitalisations in Australia. Approximately 3,700 patients are expected to benefit from this listing each year. Without subsidy, patients would pay over $700 per year for Pharmacor Cinacalcet.

Vertex Pharmaceuticals’ Symdeko was listed on the PBS on 1 December 2019 for the treatment of cystic fibrosis, and will now be extended to ensure all patients with at least one residual function mutation in the CFTR gene have access to this medicine.

The Government will also extend the PBS listing of Novartis’ Sandostatin to patients with non‑functional neuroendocrine tumours of the midgut. Without the PBS subsidy, approximately 460 patients would otherwise pay more than $23,500 per year for treatment.

Enhance corporate branding and boost thought leadership to attract and retain quality employees. Health Industry Hub is the only one-stop-hub connecting Australia’s Pharma, MedTech, and Biotech industry professionals. Learn about our unique and proven media solutions developed by industry for industry.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Medical

Medical Pharma Biotech MedTech - Medical researchers support interim budget measures and urge longer-term sustainability - Research Australia

Medical researchers support interim budget measures and urge longer-term sustainability

Health Industry Hub | September 28, 2020 |

Medical News: The $700 million bail-out package for university researchers flagged for consideration in the upcoming federal budget would be […]

More


Digital & Innovation

Healthcare Technology Digital Innovations - Pfizer Australia backs digital health start-ups, an interview with Country Medical Director Dr Krishan Thiru

Pfizer Australia backs digital health start-ups, an interview with Country Medical Director

Health Industry Hub | September 28, 2020 |

Digital & Innovation: The recent Innovate Health virtual event aimed at navigating commercialisation, accelerating growth and uptake of digital health […]

More


News & Trends - Medical Technology

MedTech News - Documentation of COVID-19 screening fell short of national imperative in Australian hospitals

Documentation of COVID-19 screening fell short of national imperative in Australian hospitals, says new study

Health Industry Hub | September 28, 2020 |

MedTech News: New Australian research on COVID-19 screening of hospital patients during the first wave of the pandemic found that […]

More


News & Trends - Pharmaceuticals

Pharma News - Roche's haemophilia treatment available at no cost to patients

Roche’s haemophilia treatment available at no cost to patients

Health Industry Hub | September 28, 2020 |

Pharma News: The Australian government have agreed to fund a new treatment for haemophilia patients, through the national blood arrangements. […]

More